大葉大學圖書館 |

Hepatocellular carcinoma[electronic resource] :diagnosis and treatment /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.99436
書名/作者:	Hepatocellular carcinoma : diagnosis and treatment // edited by Brian I. Carr.
其他作者:	Carr, Brian I.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xxi, 596 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Liver - Cancer.
標題:	Liver - Cancer
標題:	Liver - Cancer
標題:	Medicine & Public Health.
標題:	Oncology.
標題:	Hepatology.
標題:	Surgical Oncology.
標題:	Gastroenterology.
ISBN:	9783319342146
ISBN:	9783319342122
內容註:	Part A. Causes, Biological and Molecular bases of HCC -- Chapter 1. Epidemiology of Hepatocellular Carcinoma -- Chapter 2. Environmental Carcinogens and Risk for Human Liver Cancer -- Chapter 3. Molecular Mechanisms of Hepatocellular Carcinoma -- Chapter 4. Chemically-Induced Hepatocarcinogenesis -- Chapter 5. Molecular Profiling of Human Hepatocellular Carcinoma -- Chapter 6. Genomic signatures of risk factors and molecular identification of HCC subtypes -- Chapter 7. MicroRNAs and hepatocellular carcinoma -- Chapter 8. Non-tumor prognostic factors in hepatocellular carcinoma -- Chapter 9. Gut microbiota and HCC -- Chapter 10. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer -- Chapter 11. HCC and its Microenvironment -- Chapter 12. Circulating tumor cells (Liquid Tumor Biopsy) in hepatocellular carcinoma: biology, methodologies, and clinical implications -- Chapter 13. Role of the immune system in hepatocellular carcinoma: Implications for existing and novel therapies -- Chapter 14. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma -- Chapter 15. Systemic inflammation: a new prognostic domain and source of therapeutic targets in hepatocellular carcinoma -- Chapter 16. Hepatocellular Carcinoma Associated with Hepatitis B virus -- Chapter 17. Hepatitis C and Hepatocellular Carcinoma -- Chapter 18. Obesity, NASH and HCC -- Chapter 19. Metabolic Disease and Hepatocellular Carcinoma -- Part B. Diagnosis -- Chapter 20. Pathologic Aspects of Hepatocellular Tumors -- Chapter 21. Protein biomarkers in the management of hepatocellular carcinoma: Novel combinatory approaches -- Chapter 22. Surveillance for hepatocellular carcinoma -- Chapter 23. Use of Imaging Techniques to Screen for Hepatocellular Carcinoma -- Chapter 24. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement -- Chapter 25. MRI for Detection and Evaluation of Hepatocellular Carcinoma -- Chapter 26. Computed Tomography of HCC -- Chapter 27. Clinical features and clinician's diagnostic approach to hepatocellular carcinoma -- Chapter 28. Current HCC Staging systems: their uses and limitations -- Part C. Therapies -- Chapter 29. Percutaneous Ethanol Injection -- Chapter 30. Thermal Ablative Treatments For Hepatocellular Carcinoma -- Chapter 31. Resection of Hepatocellular Carcinoma -- Chapter 32. Liver Transplantation for Hepatocellular Carcinoma -- Chapter 33. Medical Therapy of HCC -- Chapter 34. Targeted therapies for Hepatocellular Carcinoma -- Chapter 35. Radiation Therapy for Hepatocellular Carcinoma -- Chapter 36. Psychosocial Issues in Hepatocellular carcinoma -- Chapter 37. Bringing it all together.
電子資源:	http://dx.doi.org/10.1007/978-3-319-34214-6

Hepatocellular carcinoma[electronic resource] :diagnosis and treatment /
Hepatocellular carcinomadiagnosis and treatment /[electronic resource] :edited by Brian I. Carr. - 3rd ed. - Cham :Springer International Publishing :2016. - xxi, 596 p. :ill. (some col.), digital ;24 cm. - Current clinical oncology. - Current clinical oncology..

Part A. Causes, Biological and Molecular bases of HCC -- Chapter 1. Epidemiology of Hepatocellular Carcinoma -- Chapter 2. Environmental Carcinogens and Risk for Human Liver Cancer -- Chapter 3. Molecular Mechanisms of Hepatocellular Carcinoma -- Chapter 4. Chemically-Induced Hepatocarcinogenesis -- Chapter 5. Molecular Profiling of Human Hepatocellular Carcinoma -- Chapter 6. Genomic signatures of risk factors and molecular identification of HCC subtypes -- Chapter 7. MicroRNAs and hepatocellular carcinoma -- Chapter 8. Non-tumor prognostic factors in hepatocellular carcinoma -- Chapter 9. Gut microbiota and HCC -- Chapter 10. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer -- Chapter 11. HCC and its Microenvironment -- Chapter 12. Circulating tumor cells (Liquid Tumor Biopsy) in hepatocellular carcinoma: biology, methodologies, and clinical implications -- Chapter 13. Role of the immune system in hepatocellular carcinoma: Implications for existing and novel therapies -- Chapter 14. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma -- Chapter 15. Systemic inflammation: a new prognostic domain and source of therapeutic targets in hepatocellular carcinoma -- Chapter 16. Hepatocellular Carcinoma Associated with Hepatitis B virus -- Chapter 17. Hepatitis C and Hepatocellular Carcinoma -- Chapter 18. Obesity, NASH and HCC -- Chapter 19. Metabolic Disease and Hepatocellular Carcinoma -- Part B. Diagnosis -- Chapter 20. Pathologic Aspects of Hepatocellular Tumors -- Chapter 21. Protein biomarkers in the management of hepatocellular carcinoma: Novel combinatory approaches -- Chapter 22. Surveillance for hepatocellular carcinoma -- Chapter 23. Use of Imaging Techniques to Screen for Hepatocellular Carcinoma -- Chapter 24. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement -- Chapter 25. MRI for Detection and Evaluation of Hepatocellular Carcinoma -- Chapter 26. Computed Tomography of HCC -- Chapter 27. Clinical features and clinician's diagnostic approach to hepatocellular carcinoma -- Chapter 28. Current HCC Staging systems: their uses and limitations -- Part C. Therapies -- Chapter 29. Percutaneous Ethanol Injection -- Chapter 30. Thermal Ablative Treatments For Hepatocellular Carcinoma -- Chapter 31. Resection of Hepatocellular Carcinoma -- Chapter 32. Liver Transplantation for Hepatocellular Carcinoma -- Chapter 33. Medical Therapy of HCC -- Chapter 34. Targeted therapies for Hepatocellular Carcinoma -- Chapter 35. Radiation Therapy for Hepatocellular Carcinoma -- Chapter 36. Psychosocial Issues in Hepatocellular carcinoma -- Chapter 37. Bringing it all together.

ISBN: 9783319342146

Standard No.: 10.1007/978-3-319-34214-6doiSubjects--Topical Terms:

448021
Liver
--Cancer.

LC Class. No.: RC280.L5

Dewey Class. No.: 616.99436

Hepatocellular carcinoma[electronic resource] :diagnosis and treatment /
LDR:03683nmm a2200325 a 4500 001 465826
003 DE-He213
005 20170118151552.0
006 m d
007 cr nn 008maaau
008 170411s2016 gw s 0 eng d
020 $a 9783319342146 $q (electronic bk.)
020 $a 9783319342122 $q (paper)
024 7 $a 10.1007/978-3-319-34214-6 $2 doi
035 $a 978-3-319-34214-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99436 $2 23
090 $a RC280.L5 $b H529 2016
245 0 0 $a Hepatocellular carcinoma $h [electronic resource] : $b diagnosis and treatment / $c edited by Brian I. Carr.
250 $a 3rd ed.
260 $a Cham : $c 2016. $b Springer International Publishing : $b Imprint: Springer,
300 $a xxi, 596 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Current clinical oncology
505 0 $a Part A. Causes, Biological and Molecular bases of HCC -- Chapter 1. Epidemiology of Hepatocellular Carcinoma -- Chapter 2. Environmental Carcinogens and Risk for Human Liver Cancer -- Chapter 3. Molecular Mechanisms of Hepatocellular Carcinoma -- Chapter 4. Chemically-Induced Hepatocarcinogenesis -- Chapter 5. Molecular Profiling of Human Hepatocellular Carcinoma -- Chapter 6. Genomic signatures of risk factors and molecular identification of HCC subtypes -- Chapter 7. MicroRNAs and hepatocellular carcinoma -- Chapter 8. Non-tumor prognostic factors in hepatocellular carcinoma -- Chapter 9. Gut microbiota and HCC -- Chapter 10. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer -- Chapter 11. HCC and its Microenvironment -- Chapter 12. Circulating tumor cells (Liquid Tumor Biopsy) in hepatocellular carcinoma: biology, methodologies, and clinical implications -- Chapter 13. Role of the immune system in hepatocellular carcinoma: Implications for existing and novel therapies -- Chapter 14. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma -- Chapter 15. Systemic inflammation: a new prognostic domain and source of therapeutic targets in hepatocellular carcinoma -- Chapter 16. Hepatocellular Carcinoma Associated with Hepatitis B virus -- Chapter 17. Hepatitis C and Hepatocellular Carcinoma -- Chapter 18. Obesity, NASH and HCC -- Chapter 19. Metabolic Disease and Hepatocellular Carcinoma -- Part B. Diagnosis -- Chapter 20. Pathologic Aspects of Hepatocellular Tumors -- Chapter 21. Protein biomarkers in the management of hepatocellular carcinoma: Novel combinatory approaches -- Chapter 22. Surveillance for hepatocellular carcinoma -- Chapter 23. Use of Imaging Techniques to Screen for Hepatocellular Carcinoma -- Chapter 24. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement -- Chapter 25. MRI for Detection and Evaluation of Hepatocellular Carcinoma -- Chapter 26. Computed Tomography of HCC -- Chapter 27. Clinical features and clinician's diagnostic approach to hepatocellular carcinoma -- Chapter 28. Current HCC Staging systems: their uses and limitations -- Part C. Therapies -- Chapter 29. Percutaneous Ethanol Injection -- Chapter 30. Thermal Ablative Treatments For Hepatocellular Carcinoma -- Chapter 31. Resection of Hepatocellular Carcinoma -- Chapter 32. Liver Transplantation for Hepatocellular Carcinoma -- Chapter 33. Medical Therapy of HCC -- Chapter 34. Targeted therapies for Hepatocellular Carcinoma -- Chapter 35. Radiation Therapy for Hepatocellular Carcinoma -- Chapter 36. Psychosocial Issues in Hepatocellular carcinoma -- Chapter 37. Bringing it all together.
650 0 $a Liver $x Cancer. $3 448021
650 0 $a Liver $x Cancer $x Diagnosis. $3 557771
650 0 $a Liver $x Cancer $x Treatment. $3 557772
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Oncology. $3 205017
650 2 4 $a Hepatology. $3 464193
650 2 4 $a Surgical Oncology. $3 465555
650 2 4 $a Gastroenterology. $3 382240
700 1 $a Carr, Brian I. $3 592242
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Current clinical oncology. $3 466448
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-34214-6
950 $a Medicine (Springer-11650)